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This issue of the Journal launches a new thematic series focused on the processes and mechanisms that underlie the cell dysfunction in inflammatory-related vascular diseases, a timely and appropriate topic. The primary role of inflammation in vascular diseases was predicted in the 19th century by the visionary pathologist R. Virchow [1], and lately substantiated by cell biologists and pathologists. Recent new facts and unexpected data uncovered the complexity and intricacy of the cellular mechanisms and factors involved and revealed that inflammation is
. It is now widely accepted that atherosclerosis is the result of a lipid disorder and an inflammatory process that ultimately result in atheroma formation [4] .
As shown in Fig. 1 , the initial change that takes place in atherogenesis is the increased transcytosis and retention of LDL within and outside the meshes of subendothelial hyperplasic basal lamina [5] [7] . These 
where, by interaction with glycosaminoglycans and proteins of the extracellular matrix, LDL particles undergo modifications (i.e. oxidation) and turn into pro-atherogenic modified and reassembled lipoproteins (mLp). The mLp function as neoantigens, initiating a multipart inflammatory reaction inducing the EC activation manifested by the expression of novel cell surface adhesion molecules (ICAM-1, VCAM-1, E and P selectins) and secretion of MCP-1, and subsequent recruitment of inflammatory cells (neutrophils, T lymphocytes and monocytes). Neutrophils granules released on the EC surface [6] and the cell adhesion molecules induce monocytes diapedesis, and homing within the subendothelium where they turn into activated macrophages, expressing scavenger receptors that serve in the non-regulated uptake of mLp converting the cells into macrophage-derived foam cells

